眼科黏弹性物质市场规模、份额及成长分析（按产品类型、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，全球眼科黏弹性物质市场规模将达到 117.2 亿美元，到 2025 年将成长至 130.8 亿美元，到 2033 年将成长至 314.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 11.6%。

全球眼科黏弹性器材市场正经历显着成长，这主要得益于微创眼科手术需求的不断增长以及黏弹性材料配方技术的进步。随着白内障、青光眼和老龄化黄斑部病变等眼科疾病的日益增多，使用这些器械对于确保有效的手术效果和保护患者视力至关重要。眼科手术在全球的扩张是推动市场发展的关键因素，因为眼科黏弹剂在维持眼部空间、稳定眼部组织和保护眼部组织方面发挥着至关重要的作用。此外，眼科医疗服务的可及性提高和眼部健康意识的增强，以及黏弹性自适应器械在角膜移植等复杂手术中简化手术流程的广泛应用，也推动了市场成长。

眼科黏弹剂市场按产品类型、应用、最终用户和地区进行细分。依产品类型划分，眼科黏弹剂分为凝聚型黏弹剂和分散型黏弹剂。依应用划分，眼科黏弹剂分为白内障、青光眼、角膜移植和玻璃体视网膜手术。依最终使用者划分，眼科黏弹剂分为医院、眼科诊所和其他机构。依地区划分，眼科黏弹剂分为北美、亚太、欧洲、拉丁美洲以及中东和非洲。

全球眼科黏弹性器材市场驱动因素

白内障、青光眼和老龄化黄斑部病变等眼科疾病的日益增多，显着推动了全球眼科黏弹性物质市场的成长。人口老化和生活方式的改变等因素加剧了这些疾病的盛行率，导致手术干预日益频繁。眼科黏弹性物质在这些手术中发挥着至关重要的作用，它们能够保护脆弱的眼部组织、维持眼内空间并提高手术效率。随着需要接受此类手术治疗的患者数量不断增加，对优质黏弹性物质的需求预计将进一步推动市场发展。

全球眼科黏弹性器材市场面临的限制因素

全球眼科黏弹性物质市场面临许多限制因素，其中高成本尤其突出，特别是那些采用创新材料和具有更高生物相容性的产品。这一经济壁垒为新兴市场和医疗预算有限的地区的医院和诊所带来了挑战。因此，中低收入地区的患者可能难以获得这些先进产品，主要原因是经济承受能力不足。高昂的价格分布可能会限制这些技术在医疗资源匮乏地区的普及和使用，从而阻碍市场成长，进而直接影响整体市场渗透率。

全球眼科黏弹性器材市场趋势

人工智慧 (AI) 和数位技术在眼科手术流程中的应用是全球眼科黏弹剂市场的一大趋势。这种融合透过人工智慧驱动的诊断影像和手术辅助，增强了术前规划、术中引导和术后护理。这些进步提高了黏弹剂应用的精准度，从而最大限度地降低手术风险并改善治疗效果。随着这些技术的不断发展，与先进手术系统相容的黏弹剂的应用显着增加。随着医疗专业人员寻求提高眼科手术的品质和效率，这种技术协同效应有望推动市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球眼科黏弹性物质市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 疏水性
• 亲水性
• 复杂类型

全球眼科黏弹性物质市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 黏弹性眼科用黏剂
• 可分散眼科黏弹性剂

全球眼科黏弹性剂市场规模（按成分和复合年增长率划分）（2026-2033 年）

• 透明质酸钠
• 硫酸软骨素
• 羟丙基甲基纤维素

全球眼科黏弹性物质市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 白内障手术
• 角膜手术
• 青光眼手术
• 屈光矫正手术

全球眼科黏弹性物质市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 眼科诊所

全球眼科黏弹性剂市场规模（按製剂类型和复合年增长率划分）（2026-2033 年）

• 一次使用
• 多用途

全球眼科黏弹性物质市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Alcon（Switzerland）
• Bausch+Lomb（Bausch Health）（USA）
• Carl Zeiss Meditec AG（Germany）
• Johnson & Johnson Vision（USA）
• Rayner Intraocular Lenses Limited（UK）
• Bohus Biotech AB（Sweden）
• Lifecore Biomedical LLC（USA）
• Hoya Corporation（Japan）
• Santen Pharmaceutical Co., Ltd.（Japan）
• Croma-Pharma GmbH（Austria）
• Eyekon Medical Inc.（USA）
• RUMEX International Co.（USA）
• Ziemer Ophthalmic Systems AG（Switzerland）
• Ophtechnics Unlimited（India）
• Haohai Biological Technology（China）
• Amring Pharmaceutical Inc.（USA）
• Truviz Ophthalmic（USA）
• Cima Technology Inc.（USA）

结论与建议

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 13.08 Billion in 2025 to USD 31.47 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026-2033).

The global ophthalmic viscoelastic devices market is experiencing significant growth, driven by the increasing demand for minimally invasive eye surgeries and innovations in viscoelastic material formulations. A rise in eye disorders, such as cataracts, glaucoma, and age-related macular degeneration, necessitates the use of these devices to ensure effective surgical outcomes and preserve patient vision. The expansion of ophthalmic surgical procedures worldwide is a crucial factor contributing to market development, as ophthalmic viscoelastic devices play a vital role in maintaining space, stabilizing, and protecting ocular tissues. Furthermore, enhanced access to ophthalmic care and heightened awareness of ocular health are fostering market growth, along with the popularity of viscoadaptive devices that streamline surgical processes in complex cases like corneal transplantation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The rise in eye-related conditions like cataracts, glaucoma, and age-related macular degeneration significantly contributes to the growth of the Global Ophthalmic Viscoelastic Devices market. Factors such as an aging population and various lifestyle choices are leading to a higher prevalence of these diseases, which frequently require surgical interventions. Ophthalmic viscoelastic devices play a crucial role in these procedures by safeguarding delicate ocular tissues, preserving intraocular space, and enhancing surgical efficiency. As the volume of patients needing these surgical solutions increases, the demand for superior viscoelastic devices is set to escalate, driving the market forward.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable constraint due to the elevated costs associated with advanced devices, particularly those utilizing innovative materials and improved biocompatibility. This financial barrier poses challenges for hospitals and clinics located in emerging markets or areas with constrained healthcare budgets. Consequently, patients in low and middle-income regions may find it difficult to access these advanced products, primarily due to affordability concerns. This limitation directly affects the overall market penetration, as the high price point can restrict the availability and usage of these technologies in underserved regions, hindering market growth opportunities.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend toward the integration of artificial intelligence and digital technologies within surgical workflows. This integration enhances preoperative planning, intraoperative guidance, and postoperative care by utilizing AI-driven imaging and surgical assistance. Such advancements foster precision in the application of viscoelastic devices, consequently minimizing surgical risks and improving outcomes. As these technologies continue to evolve, there is a marked increase in the adoption of viscoelastic devices that are compatible with sophisticated surgical systems. This technological synergy is poised to drive market growth as practitioners seek to enhance the quality and efficiency of ophthalmic procedures.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Hydrophobic
• Hydrophilic
• Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2026-2033)

• Market Overview
• Sodium Hyaluronate
• Chondroitin Sulfate
• Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cataract Surgery
• Corneal Surgery
• Glaucoma Surgery
• Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Single-Use
• Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • US
  • Canada
• Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (Bausch Health) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyekon Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RUMEX International Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ziemer Ophthalmic Systems AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtechnics Unlimited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haohai Biological Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amring Pharmaceutical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Truviz Ophthalmic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cima Technology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations